Clinical Trial Update: Peanut Oral Immunotherapy Study of Early Intervention for Desensitization [Phase 3]

View source ↗

Summary

Phase 3 trial update for peanut oral immunotherapy in early intervention for desensitization; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Aimmune Therapeutics Peanut Oral Immunotherapy (peanut oral immunotherapy)

Snippet

Sponsor: Aimmune Therapeutics, Inc. | Conditions: Peanut Allergy | Phase 3 | Status: COMPLETED | Results posted: 2023-03-02